Zhifei bioenter virus type 71 inactivated vaccine approved by the State Drug Administration for clinical trials
-
Last Update: 2020-06-10
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
recently, Zhifei Bio announced that theCompany(http://and its wholly-owned subsidiary Beijing Zhifei Green Bamboo Bio-
Pharmaceutical(http://Co., Ltddeveloped the "enterovirus type 71 inactivated vaccine (hereinafter referred to as the 'hand-foot-mouth-mouth disease vaccine') " to the NationalDrug(http://Theof the Drug ClinicalTesting(http:// notice (http://according to the announcement, according to the announcement, Zhifei Green Bamboo will carry out clinical trial work as soon as possible according to the requirements of the clinical trial notice, the research and development and administrative approval of the vaccineproduct(http://mainly include preclinical research;about Beijing Zhifei Green Bamboo BiologicalBeijing Zhifei Green Bamboo Biopharmaceutical Co., Ltdwas established in October 2003, is a wholly-owned holding subsidiary of Chongqing Zhifei Biological Products Co., Ltd., set vaccine research and development, production and marketing in one, registered capital of 832.1569 million yuan, for the national high-techenterprises(http://
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
